OC
GNCA

Oppenheimer & Co’s Genocea Biosciences, Inc. GNCA Stock Holding History

Oppenheimer & Co’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,250
Closed -$69K – 1409
2015
Q3 		$69K Buy
+1,250
New +$124K ﹤0.01% 1292
2014
Q3 		– Sell
-2,507
Closed -$376K – 1524
2014
Q2 		$376K Sell
2,507
-1,071
-30% -$163K 0.01% 964
2014
Q1 		$521K Buy
+3,578
New +$438K 0.02% 812

Other funds holding GNCA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Oppenheimer & Co's GNCA Position: Q4 2015 in Review

Oppenheimer & Co sold out of Genocea Biosciences, Inc. (GNCA) in Q4 2015, closing a stake of 1,250 shares — an estimated $69K sold.

Oppenheimer & Co first reported a position in GNCA in Q1 2014 and held it in 3 quarters. The position peaked at $521K in Q1 2014. 57 funds tracked by Wall St. Rank hold GNCA as of Q4 2015.

  • Oppenheimer & Co reported no remaining Genocea Biosciences, Inc. position as of Q4 2015 after selling out during the quarter.
  • Oppenheimer & Co sold 1,250 Genocea Biosciences, Inc. shares in Q4 2015, an estimated $69K.
  • Oppenheimer & Co first reported a position in Genocea Biosciences, Inc. in Q1 2014 and held it in 3 quarters.
  • Oppenheimer & Co's Genocea Biosciences, Inc. position peaked at $521K in Q1 2014.
  • 57 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q4 2015.

Based on Oppenheimer & Co's 13F filing for Q4 2015, filed 3 Feb 2016.